🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to determine the effect of relacorilant on the pha...
Status
Completed
Location
Site 01
Start Date
2022-05-25
Trial ID
NCT05347979
Treatments Being Tested
The purpose of this study is to allow continued use of pasireotide in patie...
Status
Completed
Location
Ximed Research SC - SOM230B2412
Start Date
2013-06-10
Trial ID
NCT01794793
Treatments Being Tested
Incidental findings of adrenal tumours,"incidentalomas", occur in 1-5 % in ...
Status
Terminated
Location
Århus University Hospital
Start Date
2011-06
Trial ID
NCT01246739
Treatments Being Tested
The goal of this observational study is to establish the normal reference i...
Status
Recruiting
Location
Shanghai Sixth People's Hospital
Start Date
2025-09-01
Trial ID
NCT07168122
Within this trial, the cardiovascular and mental status as well as the meta...
Status
Completed
Location
University Hospital Wuerzburg
Start Date
2014-10
Trial ID
NCT03880513
Treatments Being Tested
Background: There are many endocrine and metabolic-related conditions. Two...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2016-07-09
Trial ID
NCT02830308
This is a Phase 3, randomized, double-blind, placebo-controlled study to as...
Status
Completed
Location
Site 27
Start Date
2020-07-27
Trial ID
NCT04308590
Treatments Being Tested
CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate ...
Status
Recruiting
Location
Arizona Clinical Trials - Pecos
Start Date
2025-11-29
Trial ID
NCT07296484
Treatments Being Tested
The major goal of this study is to determine the incidence of adrenal insuf...
Status
Recruiting
Location
University of Michigan
Start Date
2024-07-19
Trial ID
NCT06430528
Treatments Being Tested
Osilodrostat has proven to be a safe and efficacious treatment for patients...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08
Trial ID
NCT07247162
Treatments Being Tested